Philippines
Medical device market intelligence for Philippines. Regulatory changes, competitor moves, and procurement trends.
Recent signals
The FDA warns against using the unregistered 'SUREPLUS DIGITAL THERMOMETER' due to safety concerns.
The FDA Philippines warns against unregistered MEDIPLAST water-resistant plasters due to safety concerns.
The FDA Philippines warns against using the unnotified medical device 'SURRMED® STERILIZED GAUZE PAD'.
The FDA warns against using the unregistered medical device 'PLAY & JOY ROSE MACA HERBAL LUBRICANT'.
Flowplast by Aso Philippines, Inc. is registered as a Class I medical device in EUDAMED.
Flowplast by Aso Philippines, Inc. is registered as a Class I medical device with UDI-DI 08422759820098.
Asia faces a plastic shortage due to the Iran war, impacting medical device supply chains and increasing prices.
Two US citizens were killed in a raid on a communist stronghold in the Philippines, raising human rights concerns.
Research priorities for surgical obstetrics and family planning in LMICs were established through expert consultation.
Three intervention types are essential to reduce antimicrobial resistance in newborns in LMICs: regulation, education, and optimisation.
Energy is vital for health in LMICs, yet many face energy poverty affecting healthcare and living conditions.
Vietnam and the Philippines trust Japan significantly, while Indonesia remains cautious due to its non-alignment policy.
The US plans a 4,000-acre tech hub in the Philippines to enhance economic security against China's tech dominance.
Southeast Asia's work-from-home policies may not significantly reduce energy costs as anticipated by governments.
The Iran energy crisis is accelerating Southeast Asia's shift to electric vehicles amid rising fuel prices.
Japan Airlines and All Nippon Airways are collaborating to recruit talent from the Philippines for the transport sector.
The Philippines is now Japan's closest security partner in Southeast Asia, enhancing military cooperation and joint exercises.
Shigella diarrhoea is prevalent in young children in LMICs, with rising antimicrobial resistance threatening public health.
Children in LMICs face significant delays in vaccinations, necessitating evidence-based strategies for improvement.
Research priorities are needed to address climate change's health impacts on women and children in LMICs.